Provided is an isolated anti-Notch1 negative regulatory region (NRR) antibody, wherein said antibody binds a Notch1 NRR with a Kd of 1 x 10-7 or stronger and wherein said antibody, when bound to said Notch1 NRR, decreases Notch1 signalling. The antibodies can be used to treat various cancers.